Skip to content

The Role of Cognitive Behaviour Therapy in Cessation of Long Term Benzodiazepine Use and Outcome at 6 months

The Role of Cognitive Behaviour Therapy in Cessation of Long Term Benzodiazepine Use and Outcome at 6 months

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12605000691640
Acronym
Benzo withdrawal program
Enrollment
100
Registered
2005-10-26
Start date
2004-07-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1 - Benzodiazepine dose reduction program initiated by General Practitioner plus immediate delivery of correspondence psychological skills program. Dose reduction is patient controlled and may take upto six months to cease use. Group 2 - Benzodiazepine dose reduction program initiated by General Practitioner plus 3 mths delayed delivery of correspondence psychological skills program. Dose reduction is patient controlled and may take upto six months to cease use.

Sponsors

Queensland Health
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
No

Inclusion criteria

a) have been receiving a daily dose of a benzodiazepine for a minimum continuous period of 3 months; and b) are on a stable maintenance dose of a benzodiazepine at the time of entry into the study (5-40 mg/day of diazepam or its equivalent).

Exclusion criteria

a) have a current diagnosis of a psychotic disorder;b) are diagnosed with a gross brain disorder;c) have concurrent alcohol or other non-benzodiazepine drug dependence; d) are in current receipt of any other psychological treatment; or e) are pregnant or nursing.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026